PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS UNDERGOING ERCP ARE AT INCREASED RISK FOR PANCREATITIS: RECTAL INDOMETHACIN SIGNIFICANTLY REDUCES THE RISK

被引：0
|
作者：
Thiruvengadam, Nikhil
Forde, Kimberly A.
Chandrasekhara, Vinay
Kochman, Michael L.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30597-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
292
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [31] USE OF ANTI-TNF THERAPY IS ASSOCIATED WITH INCREASED RISK OF ACUTE CHOLANGITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Kulkarni, Chiraag
    Murag, Soumya
    Cholankeril, George T.
    Fardeen, Touran
    Mannalithara, Ajitha
    Lerrigo, Robert
    Kamal, Ahmad
    Ahmed, Aijaz
    Goel, Aparna
    Sinha, Sidhartha R.
    GASTROENTEROLOGY, 2021, 160 (06) : S65 - S65
  • [32] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin Alone for the Prevention of Post-Ercp Pancreatitis in High Risk Patients
    Kamal, Ayesha
    Akshintala, Venkata S.
    Talukdar, Rupjyoti
    Goenka, Mahesh K.
    Kochhar, Rakesh
    Hutfless, Susan M.
    Lakhtakia, Sundeep
    Ramchandani, Mohan K.
    Sinha, Saroj
    Goud, Rajesh
    Rai, Vijay K.
    Tandan, Manu
    Gupta, Rajesh
    Ngamruengphong, Saowonee
    Kumbhari, Vivek
    Khashab, Mouen A.
    Elmunzer, Badih Joseph
    Kalloo, Anthony N.
    Reddy, Duvur N.
    Singh, Vikesh
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB78 - AB79
  • [33] Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography
    von Seth, Erik
    Arnelo, Urban
    Enochsson, Lars
    Bergquist, Annika
    LIVER INTERNATIONAL, 2015, 35 (01) : 254 - 262
  • [34] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High Risk Patients
    Kamal, A.
    Akshintala, V.
    Talukdar, R.
    Goenka, M. K.
    Kochhar, R.
    Lakhtakia, S.
    Ramchandani, M. K.
    Sinha, S.
    Goud, R.
    Rai, V. K.
    Vijay, K.
    Elmunzer, B. J.
    Khashab, M.
    Kalloo, A.
    Reddy, N.
    Singh, V. K.
    PANCREAS, 2017, 46 (10) : 1409 - 1409
  • [35] HEPATOCELLULAR CARCINOMA DOES NOT SIGNIFICANTLY CONTRIBUTE TO THE RISK OF HEPATOBILIARY MALIGNANCY IN CIRRHOTIC PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Zenouzi, R.
    Weismueller, T.
    Huebener, P.
    Schulze, K.
    Bubenheim, M.
    Manns, M. P.
    Lohse, A. W.
    Schramm, C.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S396 - S396
  • [36] Recurrent Bacterial Cholangitis as a Risk Factor of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis
    Trilianos, Panagiotis
    Limketkai, Berkeley N.
    Gurakar, Ahmet
    HEPATOLOGY, 2012, 56 : 474A - 474A
  • [37] Postprocedural Complications in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP)
    Dasu, Neethi R.
    Khalid, Yaser
    Foster, C. Jonathan
    McMahon, Donald J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S480 - S480
  • [38] STATINS PROTECT AGAINST THE RISK OF ACUTE CHOLANGITIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Kulkarni, Chiraag
    Cholankeril, George T.
    Fardeen, Touran
    Rathkey, Joseph K.
    Khan, Raja Samir
    Murag, Soumya
    Lerrigo, Robert
    Kamal, Ahmad
    Ahmed, Aijaz
    Goel, Aparna
    Sinha, Sidhartha R.
    GASTROENTEROLOGY, 2022, 162 (07) : S14 - S14
  • [39] Does indomethacin reduce the risk of thromboembolic events in patients undergoing ERCP?
    Wu, Jinqing
    Ding, Hao
    Mei, Qiao
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (05) : 862 - 862
  • [40] Risk of primary sclerosing cholangitis is increased among patients with gastritis-a nationwide cohort study
    Lindstrom, Lina
    Ekheden, Isabella
    Thuresson, Marcus
    Ludvigsson, Jonas F.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S334 - S335
12345